Drawing for C2RS CENTER FOR CLINICAL RESEARCH SOLUTIONS, INC.

USPTO serial 86711080

C2RS CENTER FOR CLINICAL RESEARCH SOLUTIONS, INC.

Reviewed by CopyMark Law Group

Reg. 4949785Status 710
Filing date
Status date
Registration date
May 3, 2016
Examiner
CAHILL, CLARE GALLAGHER
Law office
TMEG LAW OFFICE 104

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with C2RS CENTER FOR CLINICAL RESEARCH SOLUTIONS, INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan R Schau

JORDAN R SCHAU Lake Waldorf & Schau Plc141 E Michigan Ave Ste 600Kalamazoo, MI 49007-3943UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing independent review of clinical trials for business purposesSECTION 8 - CANCELLEDMar 1, 2009
042Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trialsSECTION 8 - CANCELLEDMar 1, 2009
045Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of researchSECTION 8 - CANCELLEDMar 1, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 18, 2022C8..CANCELLED SEC. 8 (6-YR)—
May 3, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 3, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 16, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Nov 16, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 16, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 16, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 12, 2015DOCKASSIGNED TO EXAMINER—
Aug 6, 2015MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance